Alopecia areata

AA · Immunology · 2 drugs · 2 indications

Autoimmune hair loss.

Competitive Landscape (2 drugs)

Drug	Company	Mechanism	Modality	Route	Stage
Olumiant	LLY	JAK inhibitor	Small molecule	ORAL	APPROVED
Rinvoq	ABBV	JAK inhibitor	Small molecule	ORAL	APPROVED

Indications (2)

Severe alopecia areata

Rinvoq PHASE3

Alopecia Areata

Olumiant APPROVED

Upcoming Catalysts

Rinvoq - Vitiligo - FDA ApprovalREGULATORY

ABBV2026

Rinvoq - GCA - FDA ApprovalREGULATORY

ABBV2026

Rinvoq - Alopecia Areata - Ph3 - Data (UP-AA)CLINICAL

ABBV2026

Rinvoq - HS - Ph3 - DataCLINICAL

ABBV2026

Rinvoq - SLE - Ph3 - DataCLINICAL

ABBV2026

Data from Supabase · Updated 2026-03-24